![Daniel Getts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Getts
Founder at Myeloid Therapeutics, Inc.
Network origin in Daniel Getts first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 9 | |
Myeloid Therapeutics, Inc.
![]() Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA.
8
| Holding Company | Biotechnology | 8 |
Curate Biosciences
![]() Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel Getts via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Metabolon, Inc.
![]() Metabolon, Inc. Packaged SoftwareTechnology Services Metabolon, Inc. operates as a health technology company. It offers precision medicine, clinical diagnostic, and metabolomics services. The firm serves to the pharmaceutical, biotechnology, consumer product industries. The company was founded in 2000 and is headquartered in Morrisville, NC. | Packaged Software | Corporate Officer/Principal | |
PRECISION BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
ALTHEADX INC | Pharmaceuticals: Major | Chief Executive Officer | |
NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Masters Business Admin Graduate Degree | |
Wake Forest University | College/University | Undergraduate Degree | |
HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Director/Board Member | |
TherapyEdge, Inc.
![]() TherapyEdge, Inc. Internet Software/ServicesTechnology Services Part of Advanced Biological Laboratories SA, TherapyEdge, Inc. provides a database for HIV patient's clinical records. The company is based in Durham, NC. TherapyEdge was acquired by Advanced Biological Laboratories SA on February 14, 2005. | Internet Software/Services | Chief Executive Officer | |
Eight Roads Capital Advisors (Hong Kong) Ltd.
![]() Eight Roads Capital Advisors (Hong Kong) Ltd. Investment ManagersFinance Eight Roads Capital Advisors (Hong Kong) Ltd(Eight Roads Capital) is a venture capital firm founded in 1900. Headquartered in Hong Kong. | Investment Managers | Corporate Officer/Principal | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Venture Fund
![]() Novartis Venture Fund Investment ManagersFinance Novartis Venture Fund provides early stage venture capital to companies in Europe, North America and Asia. The fund's focus is on the development of novel therapeutics and platforms, therefore it focuses on such sectors as Biotechnology and Biopharma. The fund makes seed and early stage investments ranging up to USD 30 million per company over its life. The fund makes follow-on and co-investments. | Investment Managers | Director/Board Member | |
Second Genome, Inc.
![]() Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
China University of Science & Technology | College/University | Undergraduate Degree | |
INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
eFFECTOR Therapeutics Operations, Inc.
![]() eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin | |
University of Pittsburgh School of Medicine | College/University | Doctorate Degree | |
Blade Therapeutics, Inc.
![]() Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
GRITSTONE BIO, INC. | Biotechnology | Founder Chairman | |
NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Shanghai Fangrun Medical Technology Co., Ltd.
![]() Shanghai Fangrun Medical Technology Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Forerunner Medical Equipment Technology Shanghai Co. Ltd. engages in the manufacture, sale of pharmaceutical products and medical equipment. The company was founded by Jie Qin in 2009 and is headquartered in Shanghai, China. | Electronic Equipment/Instruments | Director/Board Member | |
Medeor Therapeutics, Inc.
![]() Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Director/Board Member | |
Nimbus Apollo, Inc.
![]() Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Mironid Ltd.
![]() Mironid Ltd. Pharmaceuticals: MajorHealth Technology Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
STORM Therapeutics Ltd.
![]() STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member | |
LifeMine Therapeutics, Inc.
![]() LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer Ventures LLC
![]() Pfizer Ventures LLC Financial ConglomeratesFinance Part of Pfizer Inc., Pfizer Ventures LLC is a venture capital arm that invests in areas of current or future strategic interest to Pfizer. The company is based in New York, NY. Pfizer Ventures seeks to identify and invest in emerging companies that are developing breakthroughs and technologies that have the potential to enhance Pfizer's pipeline and shape the future of the industry. | Financial Conglomerates | Corporate Officer/Principal | |
KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Jnana Therapeutics, Inc.
![]() Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Dewpoint Therapeutics, Inc.
![]() Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
SALARIUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Pharmanav LLC | Corporate Officer/Principal | ||
SmithKline Beecham Pharmaceuticals Co.
![]() SmithKline Beecham Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, SmithKline Beecham Pharmaceuticals Co. is a company that manufactures drugs and vaccines. The company is based in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Creacion Ventures Management LLC
![]() Creacion Ventures Management LLC Investment ManagersFinance Creacion Ventures Management LLC (Creacion Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Creacion Ventures GP I LLC | Corporate Officer/Principal | ||
IBERE PHARMACEUTICALS | Financial Conglomerates | Director/Board Member | |
Chroma Medicine, Inc.
![]() Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Frontera Therapeutics, Inc.
![]() Frontera Therapeutics, Inc. BiotechnologyHealth Technology Frontera Therapeutics, Inc. is an American biotechnology company that focuses on the research and development of innovative drugs for various diseases such as eye, blood, genetic metabolism, neuromuscular, and others. The company is based in Shanghai, China, and has subsidiaries in Suzhou, China. Frontera Therapeutics specializes in producing high-quality and affordable recombinant adeno-associated virus (rAAV) carrier gene therapy products to meet the treatment needs of hereditary and chronic diseases. The company was founded in September 2019 by Hongyuan Capital and Obo Capital Investment, and it brings together professionals with rich experience in drug research and development, clinical research, registration, and production management. | Biotechnology | Director/Board Member |
Statistics
International
United States | 38 |
United Kingdom | 4 |
China | 4 |
Cayman Islands | 3 |
Switzerland | 2 |
Sectoral
Health Technology | 31 |
Finance | 7 |
Consumer Services | 6 |
Commercial Services | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 84 |
Director of Finance/CFO | 48 |
Corporate Officer/Principal | 42 |
Independent Dir/Board Member | 26 |
Chief Tech/Sci/R&D Officer | 15 |
Most connected contacts
Insiders | |
---|---|
Daniel Geffken | 53 |
Elaine Jones | 37 |
Wei Li | 24 |
Neil Gibson | 20 |
Andrew Allen | 18 |
Thomas Cahill | 13 |
Bruce McCreedy | 12 |
Mayur Ian Somaiya | 11 |
Mayo Pujols | 11 |
Brett Ilan Kaplan | 10 |
Michael D. Grisham | 8 |
Kevin Zikaras | 7 |
Stanley Frankel | 7 |
Richard Roomberg | 5 |
Alfonso Quintás-Cardama | 5 |
- Stock Market
- Insiders
- Daniel Getts
- Company connections